NCT04379037View on ClinicalTrials.gov

Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 27, 2020

Primary Completion Date

September 1, 2020

Study Completion Date

November 1, 2020

Conditions
Severe Acute Respiratory Syndrome Coronavirus 2
Interventions
DEVICE

Transcutaneous Auricular Vagus Nerve Stimulation

Transcutaneous vagus nerve stimulation involves stimulating the auricular branch of the vagus nerve with a imperceptible electrical current within the concha of the ear.

Trial Locations (1)

B2800DDF

Hospital Zonal Virgen del Carmen de Zárate, Zárate

Sponsors
All Listed Sponsors
lead

Nemechek Technologies

INDUSTRY